Supernus Pharmaceuticals Inc
(NAS:SUPN)
$
26.51
-0.4 (-1.49%)
Market Cap: 1.46 Bil
Enterprise Value: 1.22 Bil
PE Ratio: 0
PB Ratio: 1.57
GF Score: 84/100 Supernus Pharmaceuticals Inc (SUPN) Transcripts
- Q1 2024 Supernus Pharmaceuticals Inc Earnings Call TranscriptMay 08, 2024$31.3 (+0.48%)Earnings
- Q4 2023 Supernus Pharmaceuticals Inc Earnings Call TranscriptFeb 27, 2024$30.69 (+4.03%)Earnings
- Q3 2023 Supernus Pharmaceuticals Inc Earnings Call TranscriptNov 08, 2023$23.52 (-1.42%)Earnings
- Supernus Pharmaceuticals Inc R&D Day TranscriptOct 18, 2023
- Q2 2023 Supernus Pharmaceuticals Inc Earnings Call TranscriptAug 08, 2023$32.91 (+2.05%)Earnings
- Supernus Pharmaceuticals Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Q1 2023 Supernus Pharmaceuticals Inc Earnings Call TranscriptMay 09, 2023$36.18 (-1.66%)Earnings
- Q4 2022 Supernus Pharmaceuticals Inc Earnings Call TranscriptFeb 28, 2023$37.59 (-0.97%)Earnings
- Q3 2022 Supernus Pharmaceuticals Inc Earnings Call TranscriptNov 08, 2022$34.7 (-0.06%)Earnings
- Q2 2022 Supernus Pharmaceuticals Inc Earnings Call TranscriptAug 04, 2022$32.81 (+2.47%)Earnings
- Q1 2022 Supernus Pharmaceuticals Inc Earnings Call TranscriptMay 09, 2022$26.37 (-4.04%)Earnings
- Preliminary Q4 2021 Supernus Pharmaceuticals Inc Earnings Call TranscriptFeb 28, 2022$31.95 (+3.16%)Earnings
- Q3 2021 Supernus Pharmaceuticals Inc Earnings Call TranscriptNov 03, 2021$30.03 (-0.10%)Earnings
- Supernus Pharmaceuticals Inc Acquisition of Adamas Pharmaceuticals Inc - M&A Call TranscriptOct 11, 2021
- Supernus Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 15, 2021
- Q2 2021 Supernus Pharmaceuticals Inc Earnings Call TranscriptAug 04, 2021$27.18 (+1.08%)Earnings
- Q1 2021 Supernus Pharmaceuticals Inc Earnings Call TranscriptMay 05, 2021$30.49 (+1.30%)Earnings
- Supernus Pharmaceuticals Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 03, 2021
- Q4 2020 Supernus Pharmaceuticals Inc Earnings Call TranscriptFeb 25, 2021$29.45 (-4.82%)Earnings
- Supernus Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Q3 2020 Supernus Pharmaceuticals Inc Earnings Call TranscriptNov 04, 2020$22.47 (+23.80%)Earnings
- Supernus Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 16, 2020
- Q2 2020 Supernus Pharmaceuticals Inc Earnings Call TranscriptAug 19, 2020$23.4 (-6.59%)Earnings
- Q1 2020 Supernus Pharmaceuticals Inc Earnings Call TranscriptMay 06, 2020$23.17 (+4.51%)Earnings
- Supernus Pharmaceuticals Inc to Acquire the CNS portfolio of Us WorldMeds LLC - Conference Call TranscriptApr 29, 2020
- Q4 2019 Supernus Pharmaceuticals Inc Earnings Call TranscriptFeb 26, 2020$19.52 (-14.91%)Earnings
- Supernus Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 15, 2020
- Q3 2019 Supernus Pharmaceuticals Inc Earnings Call TranscriptNov 06, 2019$19.93 (-31.58%)Earnings
- Supernus Pharmaceuticals Inc at Morgan Stanley Healthcare Conference TranscriptSep 11, 2019
- Q2 2019 Supernus Pharmaceuticals Inc Earnings Call TranscriptAug 07, 2019$28.31 (-14.98%)Earnings
- Q1 2019 Supernus Pharmaceuticals Inc Earnings Call TranscriptMay 08, 2019$35.66 (-3.52%)Earnings
- Supernus Pharmaceuticals Inc Investor Day TranscriptApr 16, 2019
- Supernus Pharmaceuticals Inc to Discuss the SPN-812 Phase III Topline Results - Conference Call TranscriptMar 28, 2019
- Supernus Pharmaceuticals Inc at Cowen Health Care Conference TranscriptMar 13, 2019
- Q4 2018 Supernus Pharmaceuticals Inc Earnings Call TranscriptFeb 27, 2019$41.99 (+13.86%)Earnings
- 1